Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01835691 · ClinicalTrials.gov registry record · NA
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01835691 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT01835691, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is to research two questions. First, is vitamin D3 more effective than vitamin D2 in raising 25-hydroxyvitamin D \[25(OH)D\] levels in chronic kidney disease (CKD) patients? And secondly, what are the differential effects of vitamin D2 and vitamin D3 on other mineral metabolism parameters?
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 (cholecalciferol)
- DIETARY_SUPPLEMENT Vitamin D2 (ergocalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01835691
The ClinicalTrials.gov registry entry for NCT01835691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 (cholecalciferol) is the first listed.
NCT01835691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01835691 about?
NCT01835691 is a clinical study titled "Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease". This study is to research two questions. First, is vitamin D3 more effective than vitamin D2 in raising 25-hydroxyvitamin D \[25(OH)D\] levels in chronic kidney disease (CKD) patients? And secondly, what are the differential effects of vitamin D2 and vitamin D3 on other mineral metabolism parameters...
What is the current status of trial NCT01835691?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2011-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01835691?
The interventions under investigation include: Vitamin D3 (cholecalciferol) (DIETARY_SUPPLEMENT), Vitamin D2 (ergocalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01835691?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.